Beam Therapeutics Inc. (NASDAQ:BEAM), a biotechnology company at the forefront of precision genetic medicines with a market capitalization of $1.87 billion, is navigating a critical juncture in its ...

Researchers at the Broad Institute of MIT and Harvard have developed a gene-editing treatment for prion disease that extends ...

By 2025, innovations such as lab-on-a-chip technology, automation, and CRISPR-Cas9 gene editing are expected to enhance ...

CRISPR Therapeutics AG (NASDAQ:CRSP), a leading biotechnology company specializing in gene-based medicines with a market capitalization of $3.45 billion, stands at a critical juncture as it navigates ...

Bengaluru-based biotechnology startup, CrisprBits Private Limited, has inaugurated a CRISPR gene editing and diagnostics ...

"It's been incredible to merge our disease models with this gene-editing technology," Minikel said. "Our lab is very fortunate to have the opportunity to work with Eric and Sonia, who have brought ...

When four Eurasian lynxes were released illegally into the Scottish Highlands this month, it reignited a long-running debate: ...

Sonia Vallabh, senior group leader, Broad Institute of MIT and Harvard "It's been incredible to merge our disease models with this gene-editing technology," Minikel said. "Our lab is very ...

If corn was ever jealous of soybean's relationship with nitrogen-fixing bacteria, advancements in gene editing could one day ...

Colossal, values the Dallas-based startup at a staggering $10.2 billion. Besides making it the first startup founded in Texas ...